These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20362030)

  • 1. Derivation of multipotent progenitors from human circulating CD14+ monocytes.
    Seta N; Kuwana M
    Exp Hematol; 2010 Jul; 38(7):557-63. PubMed ID: 20362030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial differentiation potential of human monocyte-derived multipotential cells.
    Kuwana M; Okazaki Y; Kodama H; Satoh T; Kawakami Y; Ikeda Y
    Stem Cells; 2006 Dec; 24(12):2733-43. PubMed ID: 16888284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation.
    Kuwana M; Okazaki Y; Kodama H; Izumi K; Yasuoka H; Ogawa Y; Kawakami Y; Ikeda Y
    J Leukoc Biol; 2003 Nov; 74(5):833-45. PubMed ID: 12960274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human circulating monocytes as multipotential progenitors.
    Seta N; Kuwana M
    Keio J Med; 2007 Jun; 56(2):41-7. PubMed ID: 17609587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived stromal cell-derived factor-1 is required for the transformation of circulating monocytes into multipotential cells.
    Seta N; Okazaki Y; Miyazaki H; Kato T; Kuwana M
    PLoS One; 2013; 8(9):e74246. PubMed ID: 24066125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells.
    Fujiyama S; Amano K; Uehira K; Yoshida M; Nishiwaki Y; Nozawa Y; Jin D; Takai S; Miyazaki M; Egashira K; Imada T; Iwasaka T; Matsubara H
    Circ Res; 2003 Nov; 93(10):980-9. PubMed ID: 14525810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human circulating monocytes can express receptor activator of nuclear factor-kappaB ligand and differentiate into functional osteoclasts without exogenous stimulation.
    Seta N; Okazaki Y; Kuwana M
    Immunol Cell Biol; 2008 Jul; 86(5):453-9. PubMed ID: 18301383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors.
    Stec M; Weglarczyk K; Baran J; Zuba E; Mytar B; Pryjma J; Zembala M
    J Leukoc Biol; 2007 Sep; 82(3):594-602. PubMed ID: 17595380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors.
    Romagnani P; Annunziato F; Liotta F; Lazzeri E; Mazzinghi B; Frosali F; Cosmi L; Maggi L; Lasagni L; Scheffold A; Kruger M; Dimmeler S; Marra F; Gensini G; Maggi E; Romagnani S
    Circ Res; 2005 Aug; 97(4):314-22. PubMed ID: 16020753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurogenic potential of progenitors derived from human circulating CD14+ monocytes.
    Kodama H; Inoue T; Watanabe R; Yasutomi D; Kawakami Y; Ogawa S; Mikoshiba K; Ikeda Y; Kuwana M
    Immunol Cell Biol; 2006 Apr; 84(2):209-17. PubMed ID: 16519739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.
    Atkins GJ; Kostakis P; Vincent C; Farrugia AN; Houchins JP; Findlay DM; Evdokiou A; Zannettino AC
    J Bone Miner Res; 2006 Sep; 21(9):1339-49. PubMed ID: 16939392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors.
    Montanari M; Gemelli C; Tenedini E; Zanocco Marani T; Vignudelli T; Siena M; Zini R; Salati S; Chiossi G; Tagliafico E; Manfredini R; Grande A; Ferrari S
    Cell Death Differ; 2005 Dec; 12(12):1588-600. PubMed ID: 15947790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors.
    Awad O; Dedkov EI; Jiao C; Bloomer S; Tomanek RJ; Schatteman GC
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):758-64. PubMed ID: 16410458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin binding is required for acquisition of mesenchymal/endothelial differentiation potential in human circulating monocytes.
    Seta N; Okazaki Y; Izumi K; Miyazaki H; Kato T; Kuwana M
    Clin Dev Immunol; 2012; 2012():820827. PubMed ID: 23251222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of NKRP1A molecule on human monocytes and dendritic cells.
    Poggi A; Rubartelli A; Moretta L; Zocchi MR
    Eur J Immunol; 1997 Nov; 27(11):2965-70. PubMed ID: 9394825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cryopreserved CD14+-human monocytes after differentiation towards macrophages and stimulation with VEGF-A(165).
    Hiebl B; Fuhrmann R; Franke RP
    Clin Hemorheol Microcirc; 2008; 39(1-4):221-8. PubMed ID: 18503129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
    Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
    Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes.
    Kodama H; Inoue T; Watanabe R; Yasuoka H; Kawakami Y; Ogawa S; Ikeda Y; Mikoshiba K; Kuwana M
    Stem Cells Dev; 2005 Dec; 14(6):676-86. PubMed ID: 16433623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.
    Alviano F; Fossati V; Marchionni C; Arpinati M; Bonsi L; Franchina M; Lanzoni G; Cantoni S; Cavallini C; Bianchi F; Tazzari PL; Pasquinelli G; Foroni L; Ventura C; Grossi A; Bagnara GP
    BMC Dev Biol; 2007 Feb; 7():11. PubMed ID: 17313666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.